Inovio Pharmaceuticals Inc INO:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:28 PM EDT
8.62quote price arrow down-0.02 (-0.23%)
Volume
59,496
Close
8.64quote price arrow up+0.15 (+1.77%)
Volume
3,072,345
52 week range
5.81 - 33.79

...

Loading . . .
  • Open8.53
  • Day High8.77
  • Day Low8.40
  • Prev Close8.49
  • 52 Week High33.79
  • 52 Week High Date06/26/20
  • 52 Week Low5.81
  • 52 Week Low Date05/11/21

Key Stats

  • Market Cap1.809B
  • Shares Out209.40M
  • 10 Day Average Volume7.01M
  • Dividend-
  • Dividend Yield-
  • Beta0.61
  • YTD % Change-2.37

KEY STATS

  • Open8.53
  • Day High8.77
  • Day Low8.40
  • Prev Close8.49
  • 52 Week High33.79
  • 52 Week High Date06/26/20
  • 52 Week Low5.81
  • 52 Week Low Date05/11/21
  • Market Cap1.809B
  • Shares Out209.40M
  • 10 Day Average Volume7.01M
  • Dividend-
  • Dividend Yield-
  • Beta0.61
  • YTD % Change-2.37

RATIOS/PROFITABILITY

  • EPS (TTM)-1.12
  • P/E (TTM)-7.68
  • Fwd P/E (NTM)-9.42
  • EBITDA (MRQ)-147.967M
  • ROE (MRQ)-49.16%
  • Revenue (MRQ)6.46M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-2,846.18%
  • Debt To Equity (MRQ)2.42%

EVENTS

  • Earnings Date08/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
Inovio Pharmaceuticals, Inc. (Inovio) is a late-stage biotechnology company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases. The Company's DNA-based immunotherapies, in combination with its electroporation delivery devices, generates immune responses, in particular T cells, in the body to fight target diseases. It has completed, current or planned clinical programs of...
Simon Benito
Non-Executive Chairman
Jong Kim Ph.D.
Chief Executive Officer
Jacqueline Shea Ph.D.
Chief Operating Officer
Peter Kies
Chief Financial Officer
Address
6769 Mesa Ridge Rd
San Diego, CA
92121-2995
United States

Top Peers

SYMBOLLASTCHG%CHG
ADCT
ADC Therapeutics SA
25.34+2.09+8.99%
MDGL
Madrigal Pharmaceuticals Inc
106.35+1.14+1.08%
ALEC
Alector Inc
22.15+0.92+4.33%
REPL
Replimune Group Inc
35.63+0.23+0.65%
CNST
Constellation Pharmaceuticals Inc
33.80+0.04+0.12%